Fuller & Thaler Asset Management
GHDX

Fuller & Thaler Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Fuller & Thaler Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-104,673
Closed -$6.09M – 505
2019
Q2 		$6.09M Buy
104,673
+368
+0.4% +$21.8K 0.07% 194
2019
Q1 		$7.31M Buy
+104,305
New +$7.73M 0.09% 171

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Fuller & Thaler Asset Management's GHDX Position: Q3 2019 in Review

Fuller & Thaler Asset Management sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 104,673 shares — an estimated $6.09M sold.

Fuller & Thaler Asset Management first reported a position in GHDX in Q1 2019 and held it in 2 quarters. The position peaked at $7.31M in Q1 2019. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Fuller & Thaler Asset Management reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 104,673 Genomic Health, Inc. shares in Q3 2019, an estimated $6.09M.
  • Fuller & Thaler Asset Management first reported a position in Genomic Health, Inc. in Q1 2019 and held it in 2 quarters.
  • Fuller & Thaler Asset Management's Genomic Health, Inc. position peaked at $7.31M in Q1 2019.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Fuller & Thaler Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.